BGM0504
A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 60
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r |
| BGM0504 | n/r | n/r | n/r | n/r |
Not shown
- Semaglutide: endpoint not reported
- BGM0504: endpoint not reported